Table of Contents
- Overview
- Symptoms
- Treatment
- Prevention
- Images
Pernicious anemia is a decrease in red blood cells that occurs when the body cannot properly absorb
Pernicious anemia is a type of
See also:
Alternative Names
Macrocytic achylic anemia; Congenital pernicious anemia; Juvenile pernicious anemia; Vitamin B12 deficiency (malabsorption)
Causes, incidence, and risk factors
The body needs vitamin B12 to make red blood cells. To provide vitamin B12 to your blood cells, you need to eat enough foods containing vitamin B12, such as meat, poultry, shellfish, eggs, and dairy products.
To absorb vitamin B12, your body uses a special protein called intrinsic factor, which is released by cells in the stomach. The combination of vitamin B12 bound to intrinsic factor is absorbed in the last part of the small intestine.
When the stomach does not make enough intrinsic factor, the intestine cannot properly absorb vitamin B12.
Very rarely, infants and children are born without the ability to produce enough intrinsic factor, or the ability to absorb the combination of intrinsic factor and vitamin B12 in the small intestine. Pernicious anemia that occurs at birth (congenital) is inherited. You need the defective gene from each parent to get it.
Common causes of pernicious anemia include:
- Weakened stomach lining (atrophic gastritis)
- The body's immune system attacking the cells that make intrinsic factor (autoimmunity against gastric parietal cells) or intrinsic factor itself
The disease begins slowly and may take decades to fully establish. Although the congenital form occurs in children, pernicious anemia usually does not appear before age 30 in adults. The average age at diagnosis is 60.
Risk factors include:
- Family history of the disease
- History of autoimmune endocrine disorders, including:
Addison's disease Chronic thyroiditis Graves disease Hypoparathyroidism Hypopituitarism Myasthenia gravis Secondary amenorrhea Type 1 diabetes - Testicular dysfunction
Vitiligo
- Scandinavian or Northern European descent
See also:
Review Date: 02/01/2010
Reviewed By: David Dugdale, III, MD, Professor of Medicine, Division of General
Medicine, Department of Medicine, University of Washington School
of Medicine; and James R. Mason, MD, Oncologist, Director, Blood
and Marrow Transplantation Program and Stem Cell Processing Lab,
Scripps Clinic, Torrey Pines, California. Also reviewed by David
Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
